Gene Query: EXOSC3

Dataset Description Geneva Score
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 31.07
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 31.07
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 30.32
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 25.26
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 22.04
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 14.6
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 14.2
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 13.82
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 13.47
Identification of transcription start sites for human A549 cell line using ReCappable-seq 13.22
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.95
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 12.89
Peptidomimetic blockade of MYB in acute myeloid leukemia 12.89
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 12.69
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 12.04
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 11.66
ETV7 and interferon response 11.14
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 11.14
Comprehensive comparative analysis of 5’ end RNA sequencing methods 10.42
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 10.41
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 10.31
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.23
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 10.17
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.12
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 9.99
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 9.27
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 9.27
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 9.12
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 9.09
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.79
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 8.75
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.68
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.68
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.61
Global analysis of enhancer targets: Mosaic-seq 8.54
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 8.51
SNHG5 siRNA knock down in HCT116 cells 8.29
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 8.27
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.96
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 7.78
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.68
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 7.26
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 7.23
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 7.11
RNA-seq of Single-Cell Genotyping of Transcriptomes 7.09
Single-Cell Genotyping of Transcriptomes 7.09
CROP-Seq in Primary Human T Cells 6.95
Seletive inhibition of CDK9 in DLBCL cell lines 6.85
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 6.68
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.62
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.62
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.57
High-throughput sequencing of PROMPT-enriched samples. 6.52
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.49
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.45
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.3
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.3
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 6.05
Identification of global regulators of T-helper cell lineage specification 6.03
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 6.03
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 6.0
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.98
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 5.98
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 5.98
The landscape of alternative splicing in aggressive prostate cancers 5.81
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.78
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 5.77
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.77
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.6
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.57
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 5.57
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.23
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 5.22
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 5.22
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.21
A549 cells and MSR-A549 cells 5.21
scRNASeq analysis of cycling cardiomyocytes 5.08
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.07
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.06
LNCaP treated with iBET 4.91
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.86
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.79
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.79
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.77
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.69
Trans-differentiation of human adult peripheral blood T cells into neurons 4.66
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.65
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.61
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 4.6
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 4.6
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.59
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.59
RNAseq Study in CC-671 Treated Cal-51 Cells 4.57
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.54
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.51
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.46
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.46
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.42
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.42
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.41
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.39
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.38
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 4.36
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 4.35
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 4.35
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 4.34
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.33
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.32
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 4.32
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 4.31
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.31
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.31
Glioblastoma stem cells infected by ZIKA virus 4.29
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 4.28
Crizotinib v. DMSO in SW480 cells 4.22
O-glcnAc reprograms cellular energetics 4.22
Downregulation of DDX5/DDX17 and REST 4.21
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 4.2
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.2
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.17
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.14
Patient-derived luminal breast cancer xenografts with progestins 4.13
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 4.13
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.1
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.04
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.0
Identification of renal resident macrophages across species 4.0
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.97
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.97
Effect of drugs on transcriptomic profiles 3.93
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.93
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.93
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.92
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.88
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.87
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.87
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 3.83
Genome wide miR-191 target profile determined by RIP and gene expression profiling 3.83
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.82
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.82
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.82
Transcription control by the ENL YEATS domain in acute leukemia 3.81
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 3.81
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.79
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.77
Transcriptome sequencing of K-562 cells 3.77
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 3.77
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 3.76
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.75
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.72
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 3.65
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.62
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.61
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.58
Impact of dieldrin on transcription in Jurkat T cells 3.55
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.52
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.49
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.48
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.48
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.48
DART-seq: an antibody-free method for global m6A detection 3.48
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 3.47
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.46
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.44
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.42
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.41
The cohesin complex prevents Myc-induced replication stress 3.39
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 3.38
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.38
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.37
Transcriptome of activated human and mouse MAIT cells 3.37
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.36
Gene expression analysis of the impact of TDP-43 knockout in human cells. 3.35
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.35
Lysine benzoylation is a novel histone mark 3.32
Lysine benzoylation is a novel histone mark [RNA-seq] 3.32
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.32
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.31
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.3
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 3.3
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.29
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 3.27
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.26
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.24
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.23
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.23
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.21
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.21
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.2
Human Treg IL-12 stimulation 3.18
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 3.18
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.17
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.17
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 3.16
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 3.16
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.15
N6-methyladenine DNA Modification in Glioblastoma 3.15
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 3.11
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.11
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.11
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 3.08
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 3.08
RNA seq with AML (NB4) cells upon FTO inhibition 3.05
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.05
Cajal bodies are linked to genome conformation 3.04
Cajal bodies are linked to genome conformation [RNA-Seq] 3.04
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 3.01
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.01
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.0
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.0
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 2.98
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 2.98
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 2.97
RNA-seq analysis of control and Myc-induced U2OS cells 2.97
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 2.96
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 2.96
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.94
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.94
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 2.91
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 2.91
Depicting early human development and germ cell origin with porcine embryos 2.91
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.9
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.88
Single-cell analysis of adult human ovary using 10X genomics 2.88
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.87
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.87
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.85
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.81
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.8
Selective expression of long non-coding RNAs in a breast cancer cell progression model 2.8
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 2.8
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.8
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.8
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.78
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.77
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 2.76
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.75
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.75
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.73
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.73
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.73
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.72
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.72
Genome-wide discovery of human splicing branchpoints [RNAse] 2.71
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.69
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.67
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 2.65
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 2.61
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.59
Accurate annotation of human protein-coding small open reading frames 2.57
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.56
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.55
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.55
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.52
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.52
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.52
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.5
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.5
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 2.5
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.48
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 2.47
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.47
ARID1A regulates condensin II distribution and chromosomal partition 2.46
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 2.46
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.46
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.45
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.44
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.42
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.4
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 2.4
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 2.4
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.38
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.37
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 2.35
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 2.35
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.34
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.33
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.33
Functional role of SLIT2 and ROBO1 in trophoblasts 2.32
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 2.31
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.27
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.27
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.26
Regulating Interleukin-2 activity with engineered receptor signaling clamps 2.25
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.22
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.22
PRDM1 inhibits proliferation of human colon cancer organoids 2.21
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.2
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.2
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.2
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.17
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 2.17
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.15
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.15
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.13
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.13
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.13
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.11
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.1
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.09
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.08
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.08
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.08
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 2.05
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.02
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.02
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.01
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.01
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.99
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.98
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.98
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.95
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 1.95
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 1.95
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.94
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.94
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.92
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 1.87
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.87
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.87
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.86
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 1.83
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.83
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.82
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.82
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.79
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 1.79
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.79
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.79
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.78
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.77
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 1.76
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.74
Effect of PRDM11 depletion in U2932 cells 1.72
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.7
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.7
HBEC-shp53-PCHD7 1.7
Gene expression analysis of dengue-infected cells 1.69
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.68
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.64
SLIGRL-induced gene expression changes in NHEK cells 1.61
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.61
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.61
Functional significance of the HIV-1 Tat signature amino acid residues 1.56
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.54
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.52
Impact on erythroid progenitor type on erythroid differntiation 1.52
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.51
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.51
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.51
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.51
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.5
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.48
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.48
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 1.47
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.47
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.47
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.46
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.45
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.43
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.4
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.4
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.37
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.33
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 1.33
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 1.33
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 1.31
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.31
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.3
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.3
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.29
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 1.29
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.28
RNA seq comparison between scrambled and shGRP78 cells 1.28
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.28
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.28
RNA-seq of cells with TET1 knockout 1.25
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.23
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.21
p53 activity results in DNA replication fork processivity 1.19
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.19
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.17
MARS Seq data from human cortical organoids 1.15
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.15
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.14
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.14
U1 snRNP telescripting regulates size-function stratified human genome 1.13
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.12
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.12
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.11
Human Treg NaCl stimulation 1.11
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.1
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.1
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.09
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.08
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.08
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.08
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.07
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.07
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.02
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.0
Effect of nuclear IL-33 on gene expression 1.0
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.98
SLAM-seq for K562 endogenous mRNA decay 0.95
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.95
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.92
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.91
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.91
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.89
Ribosome profiling upon inhibition of eIF4A 0.86
Discovering human diabetes-risk gene function with genetics and physiological assays 0.86
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.85
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.8
Direct Isolation and Characterization of Human Nephron Progenitors. 0.79
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.78
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.78
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.78
Preclinical model of obesity and ER-positive breast cancer 0.75
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.75
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.74
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.72
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.72
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 0.7
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.7
RNA-seq data 0.68
RNA-seq of cancer cell lines treated with T-025 0.64
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.63
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.62
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.62
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.6
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.59
Identification of a LIF-responsive replication-competent human β cell 0.59
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.58
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.57
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.56
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.56
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.54
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.52
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.51
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.5
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.48
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.48
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.47
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.47
Genome-wide analysis of the Integrator complex (HTS) 0.47
Genome-wide analysis of the Integrator complex 0.47
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.46
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.45
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.45
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 0.44
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 0.44
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.43
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.43
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.43
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.38
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.38
CDK12 mediated transcriptional regulation in U2OS cells 0.38
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.33
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.32
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.31
Human Treg IFNg/IL-10 subpopulations 0.27
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.26
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.25
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.24
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.23
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.22
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.21
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.21
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.18
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.18
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.16
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.15
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.15
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.13
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.13
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.11
siRNA-mediated knockdown 0.1
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.09
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.08
HNRNPM-regulated splicing dependencies in prostate cancer 0.08
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.08
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.07
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.06
Function and hormonal regulation of GATA3 in human first trimester placentation 0.06
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.06
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.06
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.06
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.05
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.05
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.04
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.03
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.03
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.03
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.03
MicroRNA-125a-5p overexpression in human macrophages 0.03
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.03
RNA seq analysis of human Fetal and adult derived Enterospheres 0.03
Targeting MTHFD2 in Acute Myeloid Leukemia 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation